References
- Staudt LM, Lehardo MJ. Immunoglobulin gene transcription. Annu Rev Immunol 1991; 9: 373
- Andre-Schwartz J., Schwartz RS. Structure and function of the immune system. Hematology, Basic Principles and Practice, R. Hoffman, EJ Benz, Jr., SJ. Shattil, R Furie, HJ Cohen, LE Silberstein. Churchill Livingston Inc. 1995; 86–108
- Snapper CM, Mond JJ. Towards a comprehensive view of ummmoglobulin class switching. Immunol Today 1993; 14: 15
- Lustermans AT, Klein F. Two cases of monoclonal immunoglobulins with antistreptolysin activity: Clinical and laboratory study. J. Clin Pathol 1977; 30: 851
- Potter M., Boyce CR. Induction of plasma cell neoplasms in BALB-C mice with mineral oil and mineral oil adjuvants. Nature (Lord) 1962; 193: 1086
- Potter M. Concepts of pathogenesis and experimental models of immunoglobulin secreting tumors in animals. Neoplastic Diseases of Blood. Vol 1, PH Wiemik. Churchill Livingston, New York 1985
- Ossemnan EF, Takatsuki K. Considerations regarding the pathogenesis of the plasmacytic dyscrasias. Scand J Haematol 1964; 4: 28, suppl
- Riedel DA, Pottem LN. The epidemiology of multiple myeloma. Hematol Oncol Clin North Am 1992; 6: 225
- Zawadski ZA, Edwards GA. Dysimmunoglobulinemia in the absence of clinical features of multiple myeloma and macroglobulinemia. Am J Med 1967; 42: 67
- Kyle RA., Lust JA. Monoclonal gammopathies of undetermined significance. Semin Hematol 1989; 26: 176
- Blade J., Kyle RA. Monoclonal gammopathies of undetermined significance. Myeloma: Biology and Management, JS Malpas, DE Bergragel, RA Kyle. Oxford University Press, New York 1995; 433–462
- Hallek M, Bergsagel PL, Anderson KC. Multiple Myeloma: Increasing evidence for a multistep transformation. Blood 1998; 91: 3
- Feinman R., Sawyer J, Hardin J., Tricot G. Cytogenetics and molecular genetics in multiple myeloma. Hematol Oncol Clin North Am 1997; 11: 1
- Kyle RA. Monoclonal gammopathy of undetermined significance and Solitary Plasmacytoma: Implications for progression to overt multiple myeloma. Hematol Oncol Clin North Am 1997; 11: 71
- Kyle RA, Garton JP. The spectrum of IgM monoclonal garnmopathy in 430 cases. Mayo Clin Proc 1987; 62: 719
- Crawford J, Cox EB, Cohen HJ. Evaluation of hyperviscosity in monoclonal gammopathies. Am J Med 1985; 79: 13
- Varticovski L., Pick AL., Schattner A, Shoenfeld Y. Anti-platelet and anti-DNA IgM in Waldenstrom's Macroglobulinenia and ITP. Am J Hematol 1987; 24: 351
- Hory B, Saunier F, Wolff R. Waldenstrom's macroglobulinemia and nephrotic syndrome with minimal change lesion. Nephron 1987; 45: 68
- Brouet JC, Clauvel JP, Danon F, Klein M., Seligman M. Biological and clinical significance of cryoglobulins. Am J Med 1974; 57: 775
- Schubothe H. The cold hemagglutinin disease. Semin Hematol 1966; 3: 27
- Crisp D., Pruzanski W. B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins). Am J Med 1982; 72: 915
- Umlas J. A cryoglobuli n with cold agglutinin and erythroid stem cell suppressant properties. Transfusion 1991; 31: 361
- Kyle RA. Dysproteinemias and cryoglobulinemia. Cur-Opin Rheumatol 1989; 1: 221
- Perkins H, MacKenzie MR., Fudenberg HH. Hemostatic defects in dysproteinemias. Blood 1970; 35: 695
- Pruzanski W, Shumak H. Biologic activity of cold reactive autoantibodies. N Engl J Med 1977; 297: 536
- Buxbaum J. Mechanisms of disease: Monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol Oncol Clin North Am 1992; 6: 323
- Solomon A, Weiss DT, Katine M. Nephrotoxic potential of Bence Jones proteins. N Engl J Med 1991; 324: 1845
- Dhodapkar MV, Merlini G, Solomon A. Biology and Therapy of immunoglobulin deposition diseases. Hematol Oncol Clin North Am 1997; 11: 89
- Helms LR, Wetzel R. Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis. J Mol Brol 1996; 255: 77
- Solomon A. Light chains of immunoglobulins: Structural—genetic correlates. Blood 1986; 68: 603
- Solomon A. Clinical implications of monoclonal light chains. Semin Oncol 1986; 13: 341
- Kyle RA, Gertz MA. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45
- Sanders PW, Herresa GA. Monoclonal immunoglobulin light chain related renal diseases. Semin Nephrol 1993; 13: 324
- Rosen SM. The structure of immunoglobulins and their genes, DNA rearrangement and B-cell differentiation, motecular anomalies and some monoclonal immunoglobulins. Semin Oncol 1986; 13: 280
- Seligman M. Heavy chain diseases: Current findings and concepts. Immunol Rev 1979; 48: 145